On track for planned IND submission in mid-2026 and Phase 1 initiation in the second half of 2026 for XTX501, a potential best-in-class bispecific PD-1 / masked IL-2 Presented new preclinical data for ...
On track for planned IND submission in mid-2026 and Phase 1 initiation in the second half of 2026 for XTX501, a potential ...
U.S. Food and Drug Administration (FDA) review of oxylanthanum carbonate (OLC) New Drug Application (NDA) resubmission remains on track, with a Prescription Drug User Fee Act (PDUFA) target action dat ...
Oral presentation at ASGCT showcases breakthrough technology enabling precise in vivo genome editing in the CNS using a ...
Arvinas and Pfizer to receive $85 million in upfront and transition payments with potential for additional $320 million in ...
OpenSecrets reports that 17 drug companies in TrumpRx boosted lobbying by 23% to over $130M in 2025, outpacing the broader ...
In today's world, the scope of biology is no longer limited merely to becoming a doctor. For students pursuing biology, ...
Specialty Cancer Diagnostics Company Focused on Creating Cutting-Edge Products for Laboratories Through a Unique ...
Announced strategic collaboration with Mayo Clinic, focused on improving care in type 1 diabetes and accelerating development of SC451Continued ...
College of Agriculture, Biotechnology & Natural Resources honors achievement in academics, leadership and research at 2026 ...
An expert from Northway Biotech and Lithuania’s Minister of Economy and Innovation talk about how the country is poised to be ...
Microbial production of polyunsaturated fatty acids (PUFAs) is emerging as a sustainable alternative to traditional fish oil due to overfishing and marine ...